GA
IDYA icon

Greenspring Associates’s IDEAYA Biosciences IDYA Stock Holding History

Greenspring Associates’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,234
Closed -$213K – 11
2020
Q4 		$213K Buy
+15,234
New +$206K 0.28% 6

Other funds holding IDYA

CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Greenspring Associates's IDYA Position: Q1 2021 in Review

Greenspring Associates sold out of IDEAYA Biosciences (IDYA) in Q1 2021, closing a stake of 15,234 shares — an estimated $213K sold.

Greenspring Associates first reported a position in IDYA in Q4 2020 and held it in 1 quarter. The position peaked at $213K in Q4 2020. 89 funds tracked by Wall St. Rank hold IDYA as of Q1 2021.

  • Greenspring Associates reported no remaining IDEAYA Biosciences position as of Q1 2021 after selling out during the quarter.
  • Greenspring Associates sold 15,234 IDEAYA Biosciences shares in Q1 2021, an estimated $213K.
  • Greenspring Associates first reported a position in IDEAYA Biosciences in Q4 2020 and held it in 1 quarter.
  • Greenspring Associates's IDEAYA Biosciences position peaked at $213K in Q4 2020.
  • 89 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2021.

Based on Greenspring Associates's 13F filing for Q1 2021, filed 14 May 2021.